Neurol. praxi. 2009;10(4):237-241

Guidelines for diagnosing Alzheimer’s disease an other dementias

MUDr. Pavel Ressner, Ph.D1, doc. MUDr. Jakub Hort, Ph.D2, doc. MUDr. Irena Rektorová, Ph.D7, doc. MUDr. Aleš Bartoš, Ph.D3,4, MUDr. Robert Rusina5, MUDr. Vladimír Línek6, MUDr. Kateřina Sheardová7
1 Neurologické oddělení, Nemocnice s poliklinikou v Novém Jičíně
2 Neurologická klinika 2. LF UK a FN Motol, Praha
3 Psychiatrické centrum Praha, 3. LF UK, Praha
4 Univerzita Karlova v Praze, 3. LF a FN Královské Vinohrady, Neurologická klinika, Praha
5 Neurologická klinika IPVZ, Fakultní Thomayerova nemocnice Praha
6 Neurologická klinika 1. LF UK a VFN, Praha
7 I. neurologická klinika LF MU a FN u sv. Anny Brno

The task in writing this guideline proposes recommended diagnostics algorithm for Alzheimer´s disease, vascular dementia, frontotemporal

dementia, Parkinson´s disease with dementia, and dementia with Lewy Bodies. The aim of this guidelines for diagnosis of dementia

is to present a peer-rewiewed and evidence-based statement in order to guide the practice neurologists, geriatricians, psychiatrists,

and other specialised physicians responsible for the care of the patients with dementia. This guideline may contribute to the rational

diagnotic methods proceeding in the most common dementia disorders according to evidence-based medicine.

Keywords: dementia, Alzheimer´s disease, vascular dementia, diagnostics, guidelines.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ressner P, Hort J, Rektorová I, Bartoš A, Rusina R, Línek V, Sheardová K. Guidelines for diagnosing Alzheimer’s disease an other dementias. Neurol. praxi. 2009;10(4):237-241.
Download citation

References

  1. Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Archives of Internal Medicine 2003; 163: 2219-2229. Go to original source... Go to PubMed...
  2. DeCarli C, Murphy DG, McIntosh AR, Teichberg D, Schapiro MB, Horwitz B. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Research 1995; 57: 119-130. Go to original source... Go to PubMed...
  3. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1995; 12: 189-198. Go to original source... Go to PubMed...
  4. Gustavson AR, Cummings JL. Assessment and Treatment of Neuropsychiatric Symptoms in Alzheimer's disease. In: Richter RW, Richter ZR, eds Alzheimer's Disease. A Physician's Guide to Practical Management. New Jersey: Humana Press 2004: 371-385. Go to original source...
  5. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. British Journal of Psychiatry 1999; 174: 45-50. Go to original source... Go to PubMed...
  6. Chetelat G, Baron JC. Early diagnosis of Alzheimer's disease: Contribution of structural neuroimaging. Neuroimage 2003; 18: 525-541. Go to original source... Go to PubMed...
  7. Knopman DS, DeKosky ST, Cummings JL, Chui H, CoreyBloom J, Relkin N, Small GW, Miller B, Stevens JC. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the Amerian Academy of Neurology. Neurology 2001; 56: 1143-1153. Go to original source... Go to PubMed...
  8. Lemstra AW, van Meegen M, Baas F, van Gool WA. (Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease). Ned Tijdschr Geneeskd 2001; 145: 1467-1471.
  9. McKeith, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005 Dec 27; 65(12): 1863-1872. Go to original source... Go to PubMed...
  10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinial diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. Go to original source... Go to PubMed...
  11. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554. Go to original source... Go to PubMed...
  12. Rektorová I. Frontotemporální lobární degenerace - diagnóza z neuro-psychiatrického pomezí. Neurol. pro praxi 2006; 4: 199-202.
  13. Ressner P, Hort J, Rektorová I, Bartoš A, Rusina R, Línek V, Sheardová K. Doporučené postupy pro diagnostiku Alzheimerovy nemoci a dalších onemocnění spojených s demencí. Cesk Slov Neurol N 2008; 71/104(4): 494-501.
  14. Verbeek MM, De Jong D, Kremer HPH. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Annals of Clinical Biochemistry 2003; 40: 25-40. Go to original source... Go to PubMed...
  15. van Straaten EC, Scheltens P, Knol DL, van Buchem MA, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke 2003; 34: 1907-1912. Go to original source... Go to PubMed...
  16. Waldemar G, Dubois B, Emre M, Georges J, McKieth IG, Rossor M, Scheltens P, Tariska P, Winblad B. EFNS. Recommendations for the diagnosis and management of Alzheimer´s disease and other disorders associated with dementia: EFNS guideline. Eur j Neurol 2007; 14: 11-26. Go to original source... Go to PubMed...
  17. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Laupr?tre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S.. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000; 55: 811-815. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.